{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:41:28Z","timestamp":1792755688331,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007365","name":"Fondazione IRCCS Policlinico San Matteo","doi-asserted-by":"publisher","award":["80206"],"award-info":[{"award-number":["80206"]}],"id":[{"id":"10.13039\/100007365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["COVID-2020-12371817"],"award-info":[{"award-number":["COVID-2020-12371817"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.transci.2022.103398","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T01:26:43Z","timestamp":1644974803000},"page":"103398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment"],"prefix":"10.1016","volume":"61","author":[{"given":"Alessandro","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cassaniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e8 Camilla","family":"Sammartino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mortellaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Del Fante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"De Vitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Troletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Prati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Baldanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Percivalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perotti","family":"Cesare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.transci.2022.103398_bib0005","first-page":"152","article-title":"Convalescent plasma: new evidence for an old therapeutic tool","volume":"14","author":"Marano","year":"2016","journal-title":"Blood Transfus"},{"issue":"4","key":"10.1016\/j.transci.2022.103398_bib0010","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0272-2712(18)30722-4","article-title":"Uses of immune globulins in the prophylaxis and treatment of viral infections","volume":"7","author":"Weintrub","year":"1987","journal-title":"Clin Lab Med"},{"issue":"1","key":"10.1016\/j.transci.2022.103398_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tracli.2015.12.003","article-title":"Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow","volume":"23","author":"Garraud","year":"2016","journal-title":"Transfus Clin Biol"},{"issue":"1","key":"10.1016\/j.transci.2022.103398_bib0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.transci.2022.103398_bib0025","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/trf.14245","article-title":"Comparing transfusion reaction rates for various plasma types: a systematic review and meta-analysis\/regression","volume":"57","author":"Saadah","year":"2017","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.transci.2022.103398_bib0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tmrv.2020.02.003","article-title":"Coronavirus disease 2019: coronaviruses and blood safety","volume":"34","author":"Chang","year":"2020","journal-title":"Transfus Med Rev"},{"issue":"12","key":"10.1016\/j.transci.2022.103398_bib0035","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.transci.2022.103398_bib0040","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/trf.16208","article-title":"A retrospective study assessing the characteristics of COVID-19 convalescent plasma donors and donations","volume":"61","author":"Del Fante","year":"2021","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.transci.2022.103398_bib0045","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11739-020-02384-2","article-title":"Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol","volume":"15","author":"Perotti","year":"2020","journal-title":"Intern Emerg Med"},{"issue":"7","key":"10.1016\/j.transci.2022.103398_bib0050","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1055\/s-0040-1713433","article-title":"Challenges in the production of convalescent hyperimmune plasma in the age of COVID-19","volume":"46","author":"Franchini","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.transci.2022.103398_bib0055","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41467-020-20688-x","article-title":"Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy","volume":"12","author":"Alteri","year":"2021","journal-title":"Nat Commun"},{"issue":"24","key":"10.1016\/j.transci.2022.103398_bib0060","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.24.2001031","article-title":"Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020","volume":"25","author":"Percivalle","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.transci.2022.103398_bib0065","series-title":"American public health association","article-title":"Diagnostic procedures for viral and rickettsial infections","author":"Lennette","year":"1969"},{"issue":"5","key":"10.1016\/j.transci.2022.103398_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233947","article-title":"Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light","volume":"15","author":"Ragan","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.transci.2022.103398_bib0075","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/trf.13609","article-title":"The red blood cell storage lesion: the end of the beginning","volume":"56","author":"Glynn","year":"2016","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2022.103398_bib0080","first-page":"S6","article-title":"Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro","volume":"56 Suppl 1","author":"Cap","year":"2016","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.transci.2022.103398_bib0085","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/trf.13030","article-title":"Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment","volume":"55","author":"Keil","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2022.103398_bib0090","unstructured":"https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Risk-assessment-pneumonia-Wuhan-China-22-Jan-2020.pdf. [Accessed on 31 March 2020]."},{"issue":"4","key":"10.1016\/j.transci.2022.103398_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249069","article-title":"Low risk of SARS-CoV-2 in blood transfusion","volume":"16","author":"Owusu","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.transci.2022.103398_bib0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/vox.12937","article-title":"Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment","volume":"115","author":"Keil","year":"2020","journal-title":"Vox Sang"},{"issue":"12","key":"10.1016\/j.transci.2022.103398_bib0105","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1111\/trf.13860","article-title":"Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment","volume":"56","author":"Keil","year":"2016","journal-title":"Transfusion"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050222000581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050222000581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:55:23Z","timestamp":1778615723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050222000581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1473050222000581"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2022.103398","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2022.103398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103398"}}